van, der Heijde D

Sustained Improvements in Workplace and Household Productivity and Social Participation With Certolizumab Pegol Over 96 Weeks in Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis. [electronic resource] - Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research Nov 2014 - A387 p. digital

Publication Type: Journal Article

1524-4733

10.1016/j.jval.2014.08.2653 doi